EUVIMEDEUVIMED entdecken
Crossref

Macro-Capsule Fabrication via 3D Printing for Mesenchymal Stem Cell Encapsulation

Mehmet Ali KARACA, Derya DİLEK KANÇAĞI, Uğur ÖZBEK, Ercüment OVALI, Ozgul GOK

International Journal of Advances in Engineering and Pure Sciences · 2023

DOI: 10.7240/jeps.1115083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Advances in Engineering and Pure Sciences, 2023. Verfasst von Mehmet Ali KARACA und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Gefördert von: TUBITAK.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Cell transplantation is a widely used method to induce cell-mediated immune reactions inside the body. However, possible immune responses to the transplanted cells decrease the efficiency of applied cell therapy. This issue can be addressed by the transplantation of cells via 3D-printed polymeric capsules which encapsulate cells and protect them from immune system attacks. Cell-loaded capsules (macro or micro) have emerged as potential carriers for more efficacious cellular therapies. In this study, 3D-printed porous capsules were prepared from biodegradable and biocompatible polyester “polycaprolactone (PCL)” and this macro-capsule was evaluated as a carrier for its cell encapsulation effectiveness.

Method

The macro-capsule was designed to have dimensions of 2x5x10 mm and drawn in Autodesk Fusion 360 program. PCL was utilized for its 3D bio-printing via Axolotl Bioprinter Dual Print Head System. Leakage on the closed form of the macro-capsule was visually controlled by surface electron microscopy (SEM). Permeability of the macro-capsule was tested with trypan blue dye and human serum albumin (HSA) protein. Sterilization of the obtained macro-capsule was achieved via UV light and the cytotoxicity of the polycaprolactone capsule was tested for 24 and 72 hour incubation time periods.

Results

The semi-permeable macro-capsule was successfully obtained as closed and hollow form. Its porous structure was demonstrated using trypan blue dye. To evaluate the porosity of the macrocapsule, human serum albumin (HSA) protein release was performed from the macrocapsule. It has been shown that 98% of HSA was released from the macrocapsule within 24 hours. The polycaprolactone (PCL) macrocapsule was sterilized using UV light and was reported to show no in vitro cytotoxicity. In addition, it was shown that the cells in the macro-capsule consumed at least 10% glucose from the outside medium during 12 days of incubation, compared to 2D cell culture conditions, and were able to release at least 8% of the lactic acid molecules outside.

Conclusion

In conclusion, reproducible fabrication of polymer macro-capsule, high viability of encapsulated cells inside, and their metabolic assessment results have obviously indicated the potential of these capsules as effective carriers for living cells with transplantation-dependent cellular therapies.

Förderung

  • TUBITAK

Zitieren

APA

KARACA, M. A., KANÇAĞI, D. D., ÖZBEK, U., OVALI, E., & GOK, O. (2023). Macro-Capsule Fabrication via 3D Printing for Mesenchymal Stem Cell Encapsulation. International Journal of Advances in Engineering and Pure Sciences. https://doi.org/10.7240/jeps.1115083

Vancouver

KARACA MA, KANÇAĞI DD, ÖZBEK U, OVALI E, GOK O. Macro-Capsule Fabrication via 3D Printing for Mesenchymal Stem Cell Encapsulation. International Journal of Advances in Engineering and Pure Sciences. 2023. doi:10.7240/jeps.1115083

BibTeX
@article{KARACA2023,
  author = {KARACA, Mehmet Ali and KANÇAĞI, Derya DİLEK and ÖZBEK, Uğur and OVALI, Ercüment and GOK, Ozgul},
  title = {Macro-Capsule Fabrication via 3D Printing for Mesenchymal Stem Cell Encapsulation},
  journal = {International Journal of Advances in Engineering and Pure Sciences},
  year = {2023},
  doi = {10.7240/jeps.1115083}
}
Kostenlos starten →